| Ident. | Authors (with country if any) | Title |
|---|
| 000192 (2020) |
Stéphane Vignot [France] ; Olivier Le Blaye [France] ; Laurence Fluckiger [France] ; Sonia Errard [France] ; Benoît Marin [France] ; Elodie Chapel [France] | [Clinical trials during pandemic crisis: How to ensure safety and maintain access to innovation]. |
| 000663 (2020) |
Marcin F. Osuchowski [Autriche] ; Federico Aletti [États-Unis] ; Jean-Marc Cavaillon [France] ; Stefanie B. Flohé [Allemagne] ; Evangelos J. Giamarellos-Bourboulis [Grèce] ; Markus Huber-Lang [Allemagne] ; Borna Relja [Allemagne] ; Tomasz Skirecki [Pologne] ; Andrea Szab [Hongrie] ; Marc Maegele [Allemagne] | SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities. |
| 000718 (2020) |
P C Fragkou [Suisse] ; D. Belhadi [France] ; N. Peiffer-Smadja [France] ; C D Moschopoulos [Grèce] ; F-X Lescure [France] ; H. Janocha [Allemagne] ; E. Karofylakis [Grèce] ; Y. Yazdanpanah [France] ; F. Mentré [France] ; C. Skevaki [Allemagne] ; C. Laouénan [France] ; S. Tsiodras [Suisse] | Review of trials currently testing treatment and prevention of COVID-19. |
| 000778 (2020) |
Alimuddin Zumla [Royaume-Uni] ; Fu-Sheng Wang [République populaire de Chine] ; Giuseppe Ippolito [Italie] ; Nicola Petrosillo [Italie] ; Chiara Agrati [Italie] ; Esam I. Azhar [Arabie saoudite] ; Chao Chang [République populaire de Chine] ; Sherif A. El-Kafrawy [Arabie saoudite] ; Mohamed Osman [Royaume-Uni] ; Laurence Zitvogel [France] ; Peter R. Galle [Allemagne] ; Franco Locatelli [Italie] ; Ellen Gorman [Royaume-Uni] ; Carlos Cordon-Cardo [États-Unis] ; Cecilia O'Kane [Royaume-Uni] ; Danny Mcauley [Royaume-Uni] ; Markus Maeurer [Portugal] | Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies. |
| 000803 (2020) |
Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Néant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France] | Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. |
| 000981 (2020) |
Olivier Garraud [France] | Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials? |
| 000A31 (2020) |
Franck Touret [France] ; Xavier De Lamballerie [France] | Of chloroquine and COVID-19. |
| 000D28 (2020) |
Christophe M. Deroose [Belgique] ; Frédéric E. Lecouvet [Belgique] ; Laurence Collette [Belgique] ; Daniela E. Oprea-Lager [Belgique, Pays-Bas] ; Wolfgang G. Kunz [Belgique, Allemagne] ; Luc Bidaut [Belgique, Royaume-Uni] ; Joost J C. Verhoeff [Belgique, Pays-Bas] ; Caroline Caramella [Belgique, France] ; Egesta Lopci [Belgique, Italie] ; Bertrand Tombal [Belgique] ; Lioe-Fee De Geus-Oei [Belgique, Pays-Bas] ; Laure Fournier [Belgique, France] ; Marion Smits [Belgique, Pays-Bas] ; Nandita M. Desouza [Belgique, Royaume-Uni] | Impact of the COVID-19 crisis on imaging in oncological trials. |
| 000D72 (2020) |
Michele Maio [Italie] ; Omid Hamid [États-Unis] ; James Larkin [Royaume-Uni] ; Alessia Covre [Italie] ; Maresa Altomonte [Italie] ; Luana Calabr [Italie] ; Santosh A. Vardhana [États-Unis] ; Caroline Robert [France] ; Ramy Ibrahim [États-Unis] ; Andrea Anichini [Italie] ; Jedd D. Wolchok [États-Unis] ; Anna Maria Di Giacomo [Italie] | Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era. |
| 000E23 (2020) |
Renaud Felten [France] ; Emmanuel Chatelus [France] ; Laurent Arnaud [France] | How and why are rheumatologists relevant to COVID-19? |
| 001273 (2020) |
Stefan D. Anker [Allemagne] ; Javed Butler [États-Unis] ; Muhammad Shahzeb Khan [États-Unis] ; William T. Abraham [États-Unis] ; Johann Bauersachs [Allemagne] ; Edimar Bocchi [Brésil] ; Biykem Bozkurt [États-Unis] ; Eugene Braunwald [États-Unis] ; Vijay K. Chopra [Inde] ; John G. Cleland [Royaume-Uni] ; Justin Ezekowitz [Canada] ; Gerasimos Filippatos [Grèce] ; Tim Friede [Allemagne] ; Adrian F. Hernandez [États-Unis] ; Carolyn S P. Lam [Singapour, Pays-Bas] ; Joann Lindenfeld [États-Unis] ; John J V. Mcmurray [Royaume-Uni] ; Mandeep Mehra [États-Unis] ; Marco Metra [Italie] ; Milton Packer [États-Unis] ; Burkert Pieske [Allemagne] ; Stuart J. Pocock [Royaume-Uni] ; Piotr Ponikowski [Pologne] ; Giuseppe M C. Rosano [Italie, Royaume-Uni] ; John R. Teerlink [États-Unis] ; Hiroyuki Tsutsui [Japon] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Subodh Verma [Canada] ; Adriaan A. Voors [Pays-Bas] ; Janet Wittes [États-Unis] ; Faiez Zannad [France] ; Jian Zhang [République populaire de Chine] ; Petar Seferovic [Serbie] ; Andrew J S. Coats [Italie] | Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). |
| 001276 (2020) |
Nicolas Venisse [France] ; Gilles Peytavin [France] ; Stephane Bouchet [France] ; Marie-Claude Gagnieu [France] ; Rodolphe Garraffo [France] ; Romain Guilhaumou [France] ; Caroline Solas [France] | Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection. |
| 001319 (2020) |
Laurent Flet [France] ; Martine Tching-Sin [France] ; Adeline Chanat [France] ; Pauline Gendre [France] ; Annick Tibi [France] | Clinical trials: Management of investigational products during the COVID-19 pandemic. |
| 001342 (2020) |
Laurent Peyrin-Biroulet [France] ; Ashwin N. Ananthakrishnan [États-Unis] | Clinical Research and Trials-A "Nonessential" Victim of the COVID-19 Pandemic? |
| 001406 (2020) |
Florian Slimano [France] ; Amandine Baudouin [France] ; Jérémie Zerbit [France] ; Anne Toulemonde-Deldicque [France] ; Audrey Thomas-Schoemann [France] ; Régine Chevrier [France] ; Mikaël Daouphars [France] ; Isabelle Madelaine [France] ; Bertrand Pourroy [France] ; Jean-François Tournamille [France] ; Alain Astier [France] ; Florence Ranchon [France] ; Jean-Louis Cazin [France] ; Christophe Bardin [France] ; Catherine Rioufol [France] | Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). |
| 001681 (2020) |
Wen-Chien Ko [Taïwan] ; Jean-Marc Rolain [France] ; Nan-Yao Lee [Taïwan] ; Po-Lin Chen [Taïwan] ; Ching-Tai Huang [Taïwan] ; Ping-Ing Lee [Taïwan] ; Po-Ren Hsueh [Taïwan] | Arguments in favour of remdesivir for treating SARS-CoV-2 infections. |
| 001692 (2020) |
Nathan Peiffer-Smadja [France, Royaume-Uni] ; François-Xavier Lescure [France] ; Erwan Sallard [France] ; Philippe Ravaud [France] ; Bruno Vegreville [France] ; Jean-David Zeitoun [France] | Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19. |
| 001720 (2020) |
Katheron Intson [Canada] ; Sachin Kumar [Canada] ; Amy Botta [Canada] ; Rachael Neckles [États-Unis] ; Connie Leung [Canada] ; Ali Jawaid [Pologne] | An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19. |
| 001801 (2020) |
Daniele Piovani [Italie] ; Claudia Pansieri [Italie] ; Laurent Peyrin-Biroulet [France] ; Silvio Danese [Italie] ; Stefanos Bonovas [Italie] | A snapshot of the ongoing clinical research on COVID-19. |
| 001851 (2020) |
Alfred H J. Kim [États-Unis] ; Jeffrey A. Sparks ; Jean W. Liew [États-Unis] ; Michael S. Putman ; Francis Berenbaum ; Alí Duarte-García ; Elizabeth R. Graef ; Peter Korsten ; Sebastian E. Sattui ; Emily Sirotich [Canada] ; Manuel F. Ugarte-Gil ; Kate Webb ; Rebecca Grainger | A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. |
